watch
New Solana Listing $NEUROMEME: Early Phase Risks and Opportunities
The recent listing of $NEUROMEME on Solana has garnered attention. Its current market capitalization is approximately $67,190, with a very low price point of $0.0000672. The token is held by 196 investors, with the start date recorded on June 5, 2025. On-chain analysis shows no recent "smart money" trades within a 15-minute window, indicating minimal active institutional or influential investor engagement at this moment.
The audit reveals that it is not a honeypot, but it does not have a burn pool, nor is it blacklisted, possibly reducing some scam risks. Developer holdings include 0.17 SOL, and a significant share of 42.95% is held by the top 10 holders, which could imply centralization risks.
The related social presence is confirmed via Twitter and a website, but no Telegram community is currently active. Risk disclosures emphasize the high volatility and potential for scams in the crypto space; investors are advised to perform their own due diligence, avoid FOMO, and be cautious of rug pulls.
This new listing appears to be in its early trading phase with limited on-chain activity and a concentrated holder base, typical for recent launches. The transparency measures are present, yet the low liquidity and inactive smart money suggest traders should proceed cautiously. The community should stay alert for updates and conduct thorough research before considering investment.
Source available for registered users Sign Up Free
AI Analysis
The recent launch of $NEUROMEME on the Solana blockchain marks its entry into the cryptocurrency market amidst typical early-stage challenges. With a market cap of just over $67,000, it is indicative ...
AI Recommendation
Given its early stage and limited on-chain activity, the most prudent approach is to hold a cautious watch. Investors should avoid rushing into buying until the project demonstrates more active tradin...
Disclaimer
The AI analysis and recommendations provided are for informational purposes only. Any investment decisions should be made at your own risk. Past performance is not indicative of future results. Always conduct your own research and consider consulting with a financial advisor before making any investment decisions.
You might also be interested in:
don't buy
don't buy
risky